Autologous CD34+ cell therapy for refractory angina: 2-year outcomes from the ACT34-CMI study

ACT34-CMI Investigators

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'Autologous CD34+ cell therapy for refractory angina: 2-year outcomes from the ACT34-CMI study'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science